JN.1 tietoutta. BA.2.86 alalinjoja

BA.2.86* (BA.2.86X)

BA.2.86

Sublineages:BA.2.86.1 • BA.2.86.2 • BA.2.86.3 • BA.2.86.4 • JN.1 • JN.2 • JN.2.1 • JN.3 • JN.3.1 • JN.4 • JN.5 • JN.5.1 • JN.6 • JN.7 • JN.8 • JN.9 • JN.10 • JQ.1

WHO: BA.2.86* (BA.2.86X

 

 

 

JN.1 Publications & Resources

8 results

Publication

XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variantsShilpi Jain et al.bioRxiv 5 February 2024

Publication

Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmissionMehdi Benlarbi et al.bioRxiv23 January 2024

Publication

BNT162b2 XBB1.5-adapted Vaccine and COVID-19 Hospital Admissions and Ambulatory Visits in US AdultsSara Y Tartof et al.medRxiv28 December 2023

Publication

Virological characteristics of the SARS-CoV-2 JN.1 variantYu Kaku et al.bioRxiv 9 December 2023

Publication

XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against emerging SARS-CoV-2 variantsQian Wang et al.bioRxiv27 November 2023

Publication

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86 lineages combining increased fitness and antibody evasionDelphine Planas et al.bioRxiv21 November 2023

Publication

Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressureSijie Yang et al.bioRxiv16 November 2023

Publication

Evaluation of the neutralising antibody response in human and hamster sera against SARS-CoV-2 variants up to and including BA.2.86 using an authentic virus neutralisation assayNaomi S Coombes et al.bioRxiv23 October 2023